Società RLS Global AB (publ) Nasdaq Stockholm
Azioni
SE0005190725
Prodotti farmaceutici
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Roland Frösing
CEO | Chief Executive Officer | 64 | 01/01/21 |
Director of Finance/CFO | 64 | 22/08/23 | |
Magnus Nolmark
COO | Chief Operating Officer | 59 | 01/01/21 |
Susanne Olausson
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/01/17 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 71 | 01/08/12 | |
Director/Board Member | 63 | 01/08/17 | |
Anders Edvell
BRD | Director/Board Member | 55 | 01/01/23 |
Roland Frösing
CEO | Chief Executive Officer | 64 | 01/01/21 |
Lars Johansson
CHM | Chairman | 58 | 01/01/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 79 874 705 | 41 780 367 ( 52,31 %) | 0 | 52,31 % |
Coordinate società
![Indirizzo RLS Global AB (publ)](https://cdn.zonebourse.com/static/address/64310235.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+62,16% | 841 Mrd | |
+40,42% | 625 Mrd | |
-4,46% | 360 Mrd | |
+17,78% | 327 Mrd | |
+10,47% | 300 Mrd | |
+15,75% | 242 Mrd | |
+17,92% | 227 Mrd | |
+14,97% | 174 Mrd | |
+0,64% | 162 Mrd |